USPTO serial 79271602
U UNI-QLEAVER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 20, 2020
- Examiner
- CROWLEY, SEAN MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with U UNI-QLEAVER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $1,275
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cynthia Johnson Walden
Cynthia Johnson Walden Fish & Richardson P.C.P.O. Box 1022Minneapolis, MN 55440-1022UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; biological preparations for use in industry and science; Reagents for scientific and research use, Diagnostic preparations for scientific or research use; cross linking agents being industrial chemicals for use in industry and science; polyethylene glycols for use in industry and science; chemical structures being industrial chemicals, namely, phosphotriester linkers | ACTIVE | — |
| 005 | Pharmaceuticals, medical and veterinary preparations for the treatment of cancer, cardiovascular disease, respiratory disorders, metabolic disorders, autoimmune disease, neurologic and psychiatric disorders and infectious disease; pharmaceutical preparations, namely, a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; reagents for medical and veterinary uses; pharmaceutical substances being diagnostic, preparations and substances for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents, substances and contrast media for medical and veterinary purposes | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis, testing and development in the field of pharmaceuticals, of pharmaceutical, medical and veterinary preparations, reagents and substances, and of diagnostic preparations, reagents and substances; PEGylation pharmaceuticals research services; industrial analysis and industrial research services in the field of pharmaceutical testing; product design, testing and development in the field of medical technology; information and advice regarding the aforementioned services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by QuiaPEG Pharmaceuticals AB
- Other trademarks owned by QuiaPEG Pharmaceuticals AB
- Other trademarks owned by QuiaPEG Pharmaceuticals AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named U UNI-QLEAVER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 23, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 20, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 20, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 3, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 3, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 20, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 20, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 4, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 4, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 31, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 15, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 15, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 15, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 1, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 1, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 1, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 1, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 1, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 26, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 26, 2020 | ALIE | ASSIGNED TO LIE | — |
| May 26, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 26, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 26, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 21, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 21, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 17, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 1, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 31, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 6, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 5, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 4, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 19, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 15, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 14, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |